Back to Search Start Over

Meeting report: 34th international conference on antiviral research.

Authors :
Brancale A
Carter K
Delang L
Deval J
Durantel D
Gentry BG
Jordan R
Julander JG
Lo MK
Pérez-Pérez MJ
Schang LM
Seley-Radtke KL
Shi PY
Vasudevan SG
Whitley RJ
Spengler JR
Source :
Antiviral chemistry & chemotherapy [Antivir Chem Chemother] 2022 Jan-Dec; Vol. 30, pp. 20402066221130853.
Publication Year :
2022

Abstract

As a result of the multiple gathering and travels restrictions during the SARS-CoV-2 pandemic, the annual meeting of the International Society for Antiviral Research (ISAR), the International Conference on Antiviral Research (ICAR), could not be held in person in 2021. Nonetheless, ISAR successfully organized a remote conference, retaining the most critical aspects of all ICARs, a collegiate gathering of researchers in academia, industry, government and non-governmental institutions working to develop, identify, and evaluate effective antiviral therapy for the benefit of all human beings. This article highlights the 2021 remote meeting, which presented the advances and objectives of antiviral and vaccine discovery, research, and development. The meeting resulted in a dynamic and effective exchange of ideas and information, positively impacting the prompt progress towards new and effective prophylaxis and therapeutics.

Details

Language :
English
ISSN :
2040-2066
Volume :
30
Database :
MEDLINE
Journal :
Antiviral chemistry & chemotherapy
Publication Type :
Academic Journal
Accession number :
36305015
Full Text :
https://doi.org/10.1177/20402066221130853